These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9093709)

  • 21. Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.
    Nordlinger B; Rougier P; Arnaud JP; Debois M; Wils J; Ollier JC; Grobost O; Lasser P; Wals J; Lacourt J; Seitz JF; Guimares dos Santos J; Bleiberg H; Mackiewickz R; Conroy T; Bouché O; Morin T; Baila L; van Cutsem E; Bedenne L
    Lancet Oncol; 2005 Jul; 6(7):459-68. PubMed ID: 15992694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of adjuvant therapy in colorectal cancer.
    Hesketh PJ; Bulger KN
    Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer.
    Zalcberg JR; Siderov J; Simes J
    Ann Oncol; 1996 Jan; 7(1):42-6. PubMed ID: 9081390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) in breast cancer--is it cost-effective?
    Norum J
    Acta Oncol; 2000; 39(1):33-9. PubMed ID: 10752651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress of adjuvant chemotherapy in colon cancer].
    Toge T
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.
    Soveri LM; Lamminmäki A; Hänninen UA; Karhunen M; Bono P; Osterlund P
    Acta Oncol; 2019 Apr; 58(4):398-406. PubMed ID: 30638100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
    Elsaleh H; Powell B; Soontrapornchai P; Joseph D; Goria F; Spry N; Iacopetta B
    Oncology; 2000; 58(1):52-9. PubMed ID: 10644941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
    Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
    Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
    Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
    J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy for colorectal cancer.
    Rayter Z; Leicester RJ; Mansi JL
    Ann R Coll Surg Engl; 1995 Mar; 77(2):81-4. PubMed ID: 7793820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost effectiveness analysis of two adjuvant regimens in the treatment of colorectal cancer: an interpretation of the MOSAIC Study].
    Rebesco B; Cantagalli E; Amalfitano ME
    Tumori; 2005; 91(6):suppl 1-10. PubMed ID: 16457161
    [No Abstract]   [Full Text] [Related]  

  • 32. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
    Di Costanzo F; Sobrero A; Gasperoni S; Dogliotti L; Frassineti L; Falcone A; Lionetto R; Bruzzi P; Luppi G; Gallo L; Conte P; Comandone A; Turci D; Marzola M; Folco U; Pfanner E; Mestriner M; Boni C; Galli C; Tonato M; Rosso R;
    Ann Oncol; 2003 Sep; 14(9):1365-72. PubMed ID: 12954574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
    Rougier P; Nordlinger B
    Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy.
    Matasar MJ; Sundararajan V; Grann VR; Neugut AI
    Drugs Aging; 2004; 21(2):113-33. PubMed ID: 14960128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review].
    Selke B; Lebrun T; Comte S
    Bull Cancer; 2003 Feb; 90(2):143-9. PubMed ID: 12660133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases.
    Rudroff C; Altendorf-Hoffmann A; Stangl R; Scheele J
    Langenbecks Arch Surg; 1999 Jun; 384(3):243-9. PubMed ID: 10437612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.
    Chau I; Norman AR; Cunningham D; Iveson T; Hill M; Hickish T; Lofts F; Jodrell D; Webb A; Tait D; Ross PJ; Shellito P; Oates JR
    Eur J Cancer; 2005 Jul; 41(11):1551-9. PubMed ID: 16026692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.
    Wolmark N; Wieand HS; Hyams DM; Colangelo L; Dimitrov NV; Romond EH; Wexler M; Prager D; Cruz AB; Gordon PH; Petrelli NJ; Deutsch M; Mamounas E; Wickerham DL; Fisher ER; Rockette H; Fisher B
    J Natl Cancer Inst; 2000 Mar; 92(5):388-96. PubMed ID: 10699069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.